Pharmabiz1h
Sanskritech Smart Solutions ventures into Africa, to extend novel healthcare solutions to Malawi
Sanskritech Smart Solutions, one of the fastest-growing Healthtech companies in India, announced its expansion into Africa with a significant stride into the Republic of Malawi. In a landmark move, ...
Pharmabiz2h
Kairali Ayurvedic Group opens its 2nd New Delhi Centre and 4th Centre in NCR at Siri Fort
Kairali Ayurvedic Group, a leading name in providing Ayurveda in its truest form has expanded its footprint with the opening of its new centre in the heart of South Delhi at the iconic Siri Fort ...
Pharmabiz4h
MediciNova to receive US patent covering ibudilast to treat chlorine-induced acute respiratory distress syndrome
MediciNova, Inc., a biopharmaceutical company, announced that it has received a Notice of Allowance from the US Patent and Trademark Office for a pending patent application which covers MN-166 ...
Pharmabiz4h
CDSCO approves Boehringer Ingelheim’s Spevigo to treat generalized pustular psoriasis flares in adults
The Central Drugs Standard Control Organisation (CSDCO) in India has approved Boehringer Ingelheim’s Spevigo (spesolimab) injection, a first-in-class treatment for generalized pustular psoriasis (GPP) ...
Pharmabiz5h
Genprex doses first patient in Acclaim-3 study of Reqorsa Immunogene Therapy in combo with Tecentriq to treat small cell lung cancer
Genprex doses first patient in Acclaim-3 study of Reqorsa Immunogene Therapy in combo with Tecentriq to treat small cell lung cancer: Austin, Texas Wednesday, May 15, 2024, 18:00 ...
Pharmabiz6h
Instylla completes patient enrollment in HES Hypervascular Tumour Pivotal Study
Instylla, Inc., a privately held clinical-stage company focused on developing liquid embolics for peripheral vascular embolotherapy, announced the completion of patient enrollment in the ongoing ...
Pharmabiz6h
Calliditas Therapeutics’ partner Everest Medicines introduces Nefecon in China
Calliditas Therapeutics’ partner Everest Medicines introduces Nefecon in China: Stockholm, Sweden Wednesday, May 15, 2024, 17:00 Hrs [IST] Calliditas Therapeutics AB announces t ...
Pharmabiz7h
Sanjivani Paranterals net profit grows 36.8% in FY 23-24
Our Bureau, New Delhi Wednesday, May 15, 2024, 16:45 Hrs [IST] Mumbai-based Sanjivani Paranterals has posted net profit o ...
Pharmabiz7h
Granules India net profit declines 21.5% in FY 2023-24
Hyderabad-based Granules India Ltd has posted a decline of 21.54 per cent in net profit for the fiscal year 2023-24 at Rs. 405.31 crore as against Rs. 516.59 crore during the previous fiscal year. The ...
Pharmabiz7h
US FDA accepts and grants priority review status to PTC Therapeutics’ BLA for Upstaza to treat AADC deficiency
US FDA accepts and grants priority review status to PTC Therapeutics’ BLA for Upstaza to treat AADC deficiency: Warren, New Jersey Wednesday, May 15, 2024, 16:00 Hrs [IST] PTC T ...
Pharmabiz8h
Hutchmed begins registrational phase III trial of HMPL-306 for patients with IDH1- and/or IDH2-mutated relapsed/refractory AML in China
Hutchmed begins registrational phase III trial of HMPL-306 for patients with IDH1- and/or IDH2-mutated relapsed/refractory AML in China: Hong Kong, Shanghai Wednesday, May 15, 202 ...
Pharmabiz9h
APP’s Gulf branch and Uttar Pradesh unit jointly organize one-day seminar on AI at SNS College of Pharmacy in Bihar
APP’s Gulf branch and Uttar Pradesh unit jointly organize one-day seminar on AI at SNS College of Pharmacy in Bihar: Our Bureau, Chennai Wednesday, May 15, 2024, 14:30 Hrs [IST] ...